FY18 OCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on Grants.gov.
William Gradishar was appointed chief of the Division of Hematology and Oncology at Northwestern University's Feinberg School of Medicine.
Peter Cole was named the chief of pediatric hematology/oncology at Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School and the proposed Embrace Kids Foundation Chair in Pediatric Hematology/Oncology.
The American Cancer Society Cancer Action Network has released a report examining the most common patient barriers to cancer clinical trial enrollment.
Janet WoodcockShaw, Eli LillyConway-WelchThe Society for Women's Health Research will honor Janet Woodcock, of the FDA, Christi Shaw of Eli Lilly and Co., and Colleen Conway-Welch of the Vanderbilt University School of Nursing with the Women's Health Visionary Award at its 28th Annual Awards Dinner on May 1.
Paul Billings was named chief medical officer and senior vice-president of medical affairs Natera, a company focused on non-invasive genetic testing and the analysis of circulating cell-free DNA.
A whistleblower lawsuit alleges that McKesson Corp. had been repackaging cancer drugs and charging the federal and state governments for “overfill,” extra drug that is routinely put into vials by manufacturers.
NCI's Research Project Grant pool is likely to receive the largest increase in funding in 16 years, NCI Director Norman “Ned” Sharpless said at an NCI Town Hall meeting April 10.
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.
FDA granted an accelerated approval to Blincyto (blinatumomab) to treat adults and children with B-cell precursor acute lymphoblastic leukemia who are in remission but still have minimal residual disease.
